StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3028% above fair value
$36.48+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.45BP/E 104.2Yield –

Pacira BioSciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Pacira BioSciences's profit margin for the twelve months ending Jun 30, 2026 was 2.0%. For fiscal 2025 it was 1.0%, against -14.2% the year before. The highest annual figure on record is 33.9% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20251.0%+15.2
FY2024Dec 31, 2024-14.2%−20.4
FY2023Dec 31, 20236.2%+3.8
FY2022Dec 31, 20222.4%−5.4
FY2021Dec 31, 20217.8%−26.1
FY2020Dec 31, 202033.9%+36.5
FY2019Dec 31, 2019-2.6%−2.5
FY2018Dec 31, 2018-0.1%+14.7
FY2017Dec 31, 2017-14.9%−1.1
FY2016Dec 31, 2016-13.7%−14.5
FY2015Dec 31, 20150.7%+7.7
FY2014Dec 31, 2014-6.9%+67.8
FY2013Dec 31, 2013-74.7%+59.1
FY2012Dec 31, 2012-133.8%+142.4
FY2011Dec 31, 2011-276.2%−89.7
FY2010Dec 31, 2010-186.4%+24.9
FY2009Dec 31, 2009-211.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20262.4%+5.1
Q1 FY2026Mar 31, 20261.6%−1.2
Q4 FY2025Dec 31, 20250.8%−7.7
Q3 FY2025Sep 30, 20253.0%+88.1
Q2 FY2025Jun 30, 2025-2.7%−13.3
Q1 FY2025Mar 31, 20252.8%−2.5
Q4 FY2024Dec 31, 20248.6%−5.2
Q3 FY2024Sep 30, 2024-85.1%−91.7
Q2 FY2024Jun 30, 202410.6%−4.6
Q1 FY2024Mar 31, 20245.4%+17.6
Q4 FY2023Dec 31, 202313.7%+19.6
Q3 FY2023Sep 30, 20236.6%+7.0
Q2 FY2023Jun 30, 202315.2%+3.5
Q1 FY2023Mar 31, 2023-12.2%−16.5
Q4 FY2022Dec 31, 2022-5.9%−2.7
Q3 FY2022Sep 30, 2022-0.4%−14.2
Q2 FY2022Jun 30, 202211.7%−2.3
Q1 FY2022Mar 31, 20224.3%−4.4
Q4 FY2021Dec 31, 2021-3.2%−14.3
Q3 FY2021Sep 30, 202113.8%−96.9
Q2 FY2021Jun 30, 202114.1%+23.7
Q1 FY2021Mar 31, 20218.7%+1.0
Q4 FY2020Dec 31, 202011.1%+15.1
Q3 FY2020Sep 30, 2020110.8%+116.6
Q2 FY2020Jun 30, 2020-9.6%−12.3
Q1 FY2020Mar 31, 20207.7%+10.8
Q4 FY2019Dec 31, 2019-4.0%−12.7
Q3 FY2019Sep 30, 2019-5.8%−5.0
Q2 FY2019Jun 30, 20192.7%−0.4
Q1 FY2019Mar 31, 2019-3.0%+11.3
Q4 FY2018Dec 31, 20188.7%+2.9
Q3 FY2018Sep 30, 2018-0.8%+10.5
Q2 FY2018Jun 30, 20183.0%+30.9
Q1 FY2018Mar 31, 2018-14.3%+14.4
Q4 FY2017Dec 31, 20175.8%+11.3
Q3 FY2017Sep 30, 2017-11.3%+21.1
Q2 FY2017Jun 30, 2017-27.8%–
Q1 FY2017Mar 31, 2017-28.7%–
Q4 FY2016Dec 31, 2016-5.4%–
Q3 FY2016Sep 30, 2016-32.4%–

More Pacira BioSciences figures

See a number that looks wrong?